1. Home
  2. CFLT vs DVA Comparison

CFLT vs DVA Comparison

Compare CFLT & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Confluent Inc.

CFLT

Confluent Inc.

HOLD

Current Price

$30.41

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$112.68

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFLT
DVA
Founded
2014
1994
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Misc Health and Biotechnology Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
8.2B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
CFLT
DVA
Price
$30.41
$112.68
Analyst Decision
Buy
Hold
Analyst Count
32
4
Target Price
$29.93
$145.00
AVG Volume (30 Days)
14.7M
743.4K
Earning Date
02-10-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.63
EPS
N/A
9.76
Revenue
$1,113,149,000.00
$13,317,965,000.00
Revenue This Year
$22.76
$6.50
Revenue Next Year
$16.57
$2.97
P/E Ratio
N/A
$11.37
Revenue Growth
21.57
5.14
52 Week Low
$15.64
$110.33
52 Week High
$37.90
$179.60

Technical Indicators

Market Signals
Indicator
CFLT
DVA
Relative Strength Index (RSI) 77.39 38.63
Support Level $30.09 $110.33
Resistance Level $30.33 $115.82
Average True Range (ATR) 0.12 2.31
MACD -0.24 -0.13
Stochastic Oscillator 97.87 26.30

Price Performance

Historical Comparison
CFLT
DVA

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: